Related Experiment Videos
In vitro testing of chemosensitivity in physiological hypoxia
Rita Grigoryan1, Nino Keshelava, Clarke Anderson
1Developmental Therapeutics Section, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Methods in Molecular Medicine
|May 20, 2005
Summary
Hypoxia, or low oxygen, in tumors impacts cancer progression and drug resistance. Testing anticancer drugs under physiological hypoxia conditions can improve preclinical assessments of drug efficacy.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Highly aggressive tumors often exhibit hypoxia due to rapid growth and inadequate oxygen supply.
- Tumor cell adaptation to hypoxia influences tumor progression, therapeutic response, and resistance to radiation and cytotoxic drugs.
- Physiological hypoxia is a common characteristic of solid tumors and certain tissue microenvironments.
Purpose of the Study:
- To review the impact of tumor hypoxia on the cytotoxicity of anticancer drugs.
- To discuss methods for assessing anticancer agent activity under physiological hypoxia.
- To highlight the importance of incorporating hypoxia into preclinical drug testing.
Main Methods:
- Review of experimental and clinical studies on tumor hypoxia.
- Description of laboratory methods for evaluating cytotoxic activity under physiological hypoxia.
- Assessment of single antineoplastic drugs in hypoxic conditions.
Main Results:
- Hypoxic conditions significantly affect tumor cell survival and drug resistance.
- Preclinical testing in hypoxia is crucial for accurate prediction of in vivo drug efficacy.
- Established methods allow for the assessment of drug cytotoxicity under physiologically relevant hypoxic levels.
Conclusions:
- Tumor hypoxia is a critical factor influencing anticancer drug effectiveness.
- Incorporating physiological hypoxia into preclinical drug screening enhances predictive value.
- Further research into hypoxia-modulated drug responses is essential for improving cancer therapy.